Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cethromycin vs Clarithromycin in Community-Acquired Pneumonia
NCT00336544Phase 3Completed
- Sponsor
- Advanced Life Sciences Holdings
- Start
- Jun 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cethromycin in community acquired pneumonia (CAP) (2 arms), sponsored by Advanced Life Sciences Holdings. Primary endpoints: Clinical Cures in the Intent to Treat Population and Clinical Cures in the Per Protocol Clinically Evaluable Population. Started Jun 2006; status: completed.
02
Drugs
cethromycin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00336544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00336544.